The growth in pharma markets in developing countries with emerging economies (E7 countries) has outpaced the overall growth of the global pharma market. The factors including rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases, and low-cost are driving the pharma markets in these countries with a fast pace. In 2010, pharma market in E7 countries (Brazil, Russia, China, India, Turkey, Mexico, and Indonesia) was estimated at around US$ 136 Billion, and it is expected to achieve a high growth during 2011-2014, thereby increasing their share in global pharma market.
According to our new research study on the sector titled, "Emerging Pharmaceutical Markets Globally", the pharmaceutical market in the abovementioned emerging countries is projected to grow at a double digit CAGR during 2011-2014. Currently, these markets are characterized by rapid urbanization with a change in lifestyle leading to the growth in prevalence of lifestyle diseases.
Our report has found that China has the largest pharma market out of these seven countries, followed by India, Brazil, and Russia. The maximum growth in future is expected to be in China and India due to strong government support and increasing aging population. Besides, we have identified that the prevalence of chronic diseases will remain one of the major drivers for the pharmaceutical market in the E7 counties. Growing pharma industry in emerging countries are also providing immense opportunity for contract research and manufacturing to flourish at rapid pace.
The research study provides extensive and coherent information about pharma markets in the E7 countries. It highlights several emerging opportunities growing in-line with development of pharma markets in E7 countries. The research study provides detailed statistical and analytical review on demographics, macroeconomic indicators, and disease profile. It contains all the key details that will help clients to draw up market strategies and assess opportunity areas for their success in these emerging pharma markets.
According to our new research study on the sector titled, "Emerging Pharmaceutical Markets Globally", the pharmaceutical market in the abovementioned emerging countries is projected to grow at a double digit CAGR during 2011-2014. Currently, these markets are characterized by rapid urbanization with a change in lifestyle leading to the growth in prevalence of lifestyle diseases.
Our report has found that China has the largest pharma market out of these seven countries, followed by India, Brazil, and Russia. The maximum growth in future is expected to be in China and India due to strong government support and increasing aging population. Besides, we have identified that the prevalence of chronic diseases will remain one of the major drivers for the pharmaceutical market in the E7 counties. Growing pharma industry in emerging countries are also providing immense opportunity for contract research and manufacturing to flourish at rapid pace.
The research study provides extensive and coherent information about pharma markets in the E7 countries. It highlights several emerging opportunities growing in-line with development of pharma markets in E7 countries. The research study provides detailed statistical and analytical review on demographics, macroeconomic indicators, and disease profile. It contains all the key details that will help clients to draw up market strategies and assess opportunity areas for their success in these emerging pharma markets.
- 1. Analyst View
- 2. Research Methodology
- 3. Global Pharmaceutical Market
- 3.1 Market Size
- 3.2 Mature Markets - G7 Countries
- 3.3 Emerging Markets - E7 Countries
- 3.4 E7 Countries to Grow Strongly
- 4. Why E7 Pharmaceutical Market?
- 4.1 Economic Growth
- 4.2 Income Level
- 4.3 Population Base
- 4.4 Medical & Distribution Infrastructure
- 4.5 Health Insurance
- 5. Industry Performance
- 5.1 Brazil (Past, Present & Future Scenario)
- 5.1.1 Macroeconomic Indicators
- 5.1.2 Population Profile
- 5.1.3 Disease Profile
- 5.1.4 Healthcare Spending & Financing
- 5.1.5 Pharmaceutical Market
- 5.1.6 Import & Export
- 5.1.7 Branded & Generic Drugs
- 5.1.8 Key Players
- 5.2 Russia (Past, Present & Future Scenario)
- 5.2.1 Macroeconomic Indicators
- 5.2.2 Population Profile
- 5.2.3 Disease Profile
- 5.2.4 Healthcare Spending & Financing
- 5.2.5 Pharmaceutical Market
- 5.2.6 Import
- 5.2.7 Key Players
- 5.3 India (Past, Present & Future Scenario)
- 5.3.1 Macroeconomic Indicators
- 5.3.2 Population Profile
- 5.3.3 Disease Profile
- 5.3.4 Healthcare Spending & Financing
- 5.3.5 Pharmaceutical Market
- 5.3.6 Import & Export
- 5.3.7 Branded & Generic Drugs
- 5.3.8 Key Players
- 5.4 China (Past, Present & Future Scenario)
- 5.4.1 Macroeconomic Indicators
- 5.4.2 Population Profile
- 5.4.3 Disease Profile
- 5.4.4 Healthcare Spending & Financing
- 5.4.5 Pharmaceutical Market
- 5.4.6 Import & Export
- 5.4.7 Branded & Generic Drugs
- 5.4.8 Key Players
- 5.5 Turkey (Past, Present & Future Scenario)
- 5.5.1 Macroeconomic Indicators
- 5.5.2 Population Profile
- 5.5.3 Disease Profile
- 5.5.4 Healthcare Spending & Financing
- 5.5.5 Pharmaceutical Market
- 5.5.6 Import & Export
- 5.5.7 Branded & Generic Drugs
- 5.5.8 Key Players
- 5.6 Mexico (Past, Present & Future Scenario)
- 5.6.1 Macroeconomic Indicators
- 5.6.2 Population Profile
- 5.6.3 Disease Profile
- 5.6.4 Healthcare Spending & Financing
- 5.6.5 Pharmaceutical Market
- 5.6.6 Import & Export
- 5.6.7 Branded & Generic Drugs
- 5.6.8 Key Players
- 5.7 Indonesia (Past, Present & Future Scenario)
- 5.7.1 Macroeconomic Indicators
- 5.7.2 Population Profile
- 5.7.3 Disease Profile
- 5.7.4 Healthcare Spending & Financing
- 5.7.5 Pharmaceutical Market
- 5.7.6 Import & Export
- 5.7.7 Branded & Generic Drugs
- 5.7.8 Key Players
- 6. Opportunities
- 6.1 Chronic Diseases
- 6.2 Pharma Outsourcing Market
- 6.3 Vaccine Market
- 7. Restraining Forces
- 7.1 Counterfeit Drugs
- 7.2 Patent Protection
- 7.3 Traditional Medicines
- 8. Key Players
- 8.1 GlaxoSmithKline
- 8.2 Sanofi-Aventis
- 8.3 Pfizer Inc.
- 8.4 Novartis
- 8.5 AstraZeneca
- List of Figures:
- Figure 3-1: Global - Pharmaceutical Market (Billion US$), 2009-2014
- Figure 3-2: G7 Countries - Pharmaceutical Market (Billion US$), 2010
- Figure 3-3: G7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2014
- Figure 3-4: G7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2011 to 2014
- Figure 3-5: E7 Countries - Pharmaceutical Market (Billion US$), 2010
- Figure 3-6: E7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2014
- Figure 3-7: E7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2011 to 2014
- Figure 3-8: Global - Share of E7 & G7 Countries in Pharmaceutical Market (2010 & 2014)
- Figure 4-1: G7 & E7 Countries - Nominal GDP (Trillion US$), 2010 & 2014
- Figure 4-2: Global - Share of E7 & G7 Countries Population in Total Population (2010 & 2014)
- Figure 4-3: Relative Per Capita Spending on Drugs by Age Group
- Figure 5-1: Brazil - Nominal GDP (Billion US$), 2009-2014
- Figure 5-2: Brazil - Consumer Price Index (%), 2009-2014
- Figure 5-3: Brazil - Foreign Direct Investment (Billion US$), 2009 & 2010
- Figure 5-4: Brazil - Population (Million), 2009-2014
- Figure 5-5: Brazil - Breakup of Population by Age Group (%), 2009-2014
- Figure 5-6: Brazil - Population in the Age Group of 65 Years & Above (Million), 2009-2014
- Figure 5-7: Brazil - Breakup of Deaths by Various Causes (%), 2010
- Figure 5-8: Brazil - Per Head Healthcare Spending (US$), 2009-2014
- Figure 5-9: Brazil - Breakup of Healthcare Payment by Source (%), 2010
- Figure 5-10: Brazil - Pharmaceutical Market (Billion US$), 2009-2014
- Figure 5-11: Brazil - Pharmaceutical Imports (Billion US$), 2009 & 2010
- Figure 5-12: Brazil - Pharmaceutical Exports (Billion US$), 2009 & 2010
- Figure 5-13: Brazil - Generic Drugs Market (Billion US$), 2009 & 2010
- Figure 5-14: Brazil - Share of Branded & Generic Drugs in Pharmaceutical Market (2010)
- Figure 5-15: Russia - Nominal GDP (Billion US$), 2009-2014
- Figure 5-16: Russia - Consumer Price Index (%), 2009-2014
- Figure 5-17: Russia - Foreign Direct Investment (Billion US$), 2009 & 2010
- Figure 5-18: Russia - Population (Million), 2009-2014
- Figure 5-19: Russia - Breakup of Population by Age Group (%), 2009-2014
- Figure 5-20: Russia - Population in the Age Group of 65 Years & Above (Million), 2009-2014
- Figure 5-21: Russia - Breakup of Deaths by Various Causes (%), 2010
- Figure 5-22: Russia - Per Head Healthcare Spending (US$), 2009-2014
- Figure 5-23: Russia - Breakup of Healthcare Payment by Source (%), 2010
- Figure 5-24: Russia - Pharmaceutical Market (Billion US$), 2009-2014
- Figure 5-25: Russia - Pharmaceutical Imports (Billion Rubles), 2009 & 2010
- Figure 5-26: India - Nominal GDP (Billion US$), 2009-2014
- Figure 5-27: India - Consumer Price Index (%), 2009-2014
- Figure 5-28: India - Foreign Direct Investment (Billion US$), FY 2009 & FY 2010
- Figure 5-29: India - Foreign Direct Investment in Pharmaceutical Market (Million US$), FY 2009 & FY 2010
- Figure 5-30: India - Population (Million), 2009-2014
- Figure 5-31: India - Breakup of Population by Age Group (%), 2009-2014
- Figure 5-32: India - Population in the Age Group of 65 Years & Above (Million), 2009-2014
- Figure 5-33: India - Breakup of Deaths by Various Causes (%), 2010
- Figure 5-34: India - Per Head Healthcare Spending (US$), 2009-2014
- Figure 5-35: India - Breakup of Healthcare Payment by Source (%), 2010
- Figure 5-36: India - Pharmaceutical Market (Billion US$), FY 2009 to FY 2014
- Figure 5-37: India - Pharmaceutical Imports (Billion INR), FY 2009 & FY 2010
- Figure 5-38: India - Pharmaceutical Exports (Billion INR), FY 2009 & FY 2010
- Figure 5-39: India - Breakup of Domestic Pharmaceutical Market by Segment (%), 2010
- Figure 5-40: China - Nominal GDP (Billion US$), 2009-2014
- Figure 5-41: China - Consumer Price Index (%), 2009-2014
- Figure 5-42: China - Foreign Direct Investment (Billion US$), 2009 & 2010
- Figure 5-43: China - Population (Million), 2009-2014
- Figure 5-44: China - Breakup of Population by Age Group (%), 2009-2014
- Figure 5-45: China - Population in the Age Group of 65 Years & Above (Million), 2009-2014
- Figure 5-46: China - Breakup of Deaths by Various Causes (%), 2010
- Figure 5-47: China - Per Head Healthcare Spending (US$), 2009-2014
- Figure 5-48: China - Breakup of Healthcare Payment by Source (%), 2010
- Figure 5-49: China - Pharmaceutical Market (Billion US$), 2009-2014
- Figure 5-50: China - Pharmaceutical Imports (Billion US$), 2009 & 2010
- Figure 5-51: China - Pharmaceutical Exports (Billion US$), 2009 & 2010
- Figure 5-52 China - Share of Generic Drugs in Pharmaceutical Market (2010)
- Figure 5-53: Turkey - Nominal GDP (Billion US$), 2009-2014
- Figure 5-54: Turkey - Consumer Price Index (%), 2009-2014
- Figure 5-55: Turkey - Foreign Direct Investment (Billion US$), 2009 & 2010
- Figure 5-56: Turkey - Population (Million), 2009-2014
- Figure 5-57: Turkey - Breakup of Population by Age Group (%), 2009-2014
- Figure 5-58: Turkey - Population in the Age Group of 65 Years & Above (Million), 2009-2014
- Figure 5-59: Turkey - Breakup of Deaths by Various Causes (%), 2010
- Figure 5-60: Turkey - Per Head Healthcare Spending (US$), 2009-2014
- Figure 5-61: Turkey - Breakup of Healthcare Payment by Source (%), 2010
- Figure 5-62: Turkey - Pharmaceutical Market (Billion €), 2009-2014
- Figure 5-63: Turkey - Share of Imported & Domestically Manufactured Drugs in Pharmaceutical Market (2010)
- Figure 5-64: Turkey - Pharmaceutical Exports (Million US$), 2009 & 2010
- Figure 5-65: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market by Value (2010)
- Figure 5-66: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market by Volume (2010)
- Figure 5-67: Mexico - Nominal GDP (Billion US$), 2009-2014
- Figure 5-68: Mexico - Consumer Price Index (%), 2009-2014
- Figure 5-69: Mexico - Foreign Direct Investment (Billion US$), 2009 & 2010
- Figure 5-70: Mexico - Population (Million), 2009-2014
- Figure 5-71: Mexico - Breakup of Population by Age Group (%), 2009-2014
- Figure 5-72: Mexico - Population in the Age Group of 65 Years & Above (Million), 2009-2014
- Figure 5-73: Mexico - Breakup of Deaths by Various Causes (%), 2010
- Figure 5-74: Mexico - Per Head Healthcare Spending (US$), 2009-2014
- Figure 5-75: Mexico - Breakup of Healthcare Payment by Source (%), 2010
- Figure 5-76: Mexico - Pharmaceutical Market (Billion US$), 2009-2014
- Figure 5-77: Mexico - Pharmaceutical Imports (Million US$), 2009 & 2010
- Figure 5-78: Mexico - Pharmaceutical Exports (Million US$), 2009 & 2010
- Figure 5-79: Mexico - Share of Branded & Generic Drugs in Pharmaceutical Market (2010)
- Figure 5-80: Indonesia - Nominal GDP (Billion US$), 2009-2014
- Figure 5-81: Indonesia - Consumer Price Index (%), 2009-2014
- Figure 5-82: Indonesia - Foreign Direct Investment (Billion US$), 2009 & 2010
- Figure 5-83: Indonesia - Population (Million), 2009-2014
- Figure 5-84: Indonesia - Breakup of Population by Age Group (%), 2009-2014
- Figure 5-85: Indonesia - Population in the Age Group of 65 Years & Above (Million), 2009-2014
- Figure 5-86: Indonesia - Breakup of Deaths by Various Causes (%), 2010
- Figure 5-87: Indonesia - Per Head Healthcare Spending (US$), 2009-2014
- Figure 5-88: Indonesia - Breakup of Healthcare Payment by Source (%), 2010
- Figure 5-89: Indonesia - Pharmaceutical Market (Billion US$), 2009-2014
- Figure 5-90: Indonesia - Pharmaceutical Exports (Million US$) 2009 & 2010
- Figure 5-91: Indonesia - Pharmaceutical Imports (Million US$) 2009 & 2010
- Figure 5-92: Indonesia - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
- Figure 5-93: Indonesia - Share of Top Players in Prescription Pharmaceutical Market, YTD 12 2010
- Figure 5-94: Indonesia - Share of Top Players in OTC Pharmaceutical Market (YTD 12 2010)
- List of Tables:
- Table 3-1: Global - Pharmaceutical Market by Region (Billion US$), 2010
- Table 4-1: E7 Countries - Disposable Income (Million US$), 2010 & 2014
- Table 4-2: G7 Countries - Population (Million), 2010 & 2014
- Table 4-3: E7 Countries - Population (Million), 2010 & 2014
- Table 4-4: G7 Countries - Population in the Age Group of 65 Years & Above (Million), 2010 & 2014
- Table 4-5: E7 Countries - Population in the Age Group of 65 Years & Above (Million), 2010 & 2014
- Table 5-1: Brazil - Share of Top 10 Players in Pharmaceutical Market (2010)
- Table 5-2: Russia - Top 10 Pharmaceutical Players by Sales (Million Rubles), 2010
- Table 5-3: India - Top 10 Pharmaceutical Players by Sales (Million US$), 2010
- Table 6-1: India, China & Brazil - Vaccine Market (Million US$), 2011 & 2013
- Table 8-1: GlaxoSmithKline - Strengths & Weaknesses
- Table 8-2: Sanofi-Aventis - Strengths & Weaknesses
- Table 8-3: Pfizer Inc. - Strengths & Weaknesses
- Table 8-4: Novartis - Strengths & Weaknesses
- Table 8-5: AstraZeneca - Strengths & Weaknesses
Other selected research from the 'Markets' category:
Analysis of the Pharmaceutical Market to 2012 - Segmented by Drug Target Family
Drug targets are the critical link between drugs and their role in treating diseases. This report provides a comprehensive analysis of the prescription pharmaceutical market by not just molecule type and therapy area, but also by target family. Learn More
Pharmaceuticals in China
Pharmaceuticals in China industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry. Learn More